PhaseBio, Duke University deal

PhaseBio granted the university exclusive rights to conjugate small molecule

Read the full 108 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE